MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2016 International Congress

    Atypical Parkinsonian disorders: Insights for a differential diagnosis through the analysis of oculomotor profile in MSA, PSP and CBD patients

    F. Rosini, G. Lucii, P. Federighi, E. Pretegiani, F. Giannini, R. Rocchi, A. Federico, A. Rufa (Siena, Italy)

    Objective: To determine peculiar changes in oculomotor profile that may help in distinguishing atypical parkinsonism with overlapping clinical features. Background: Atypical Parkinsonian disorders (APDs) include…
  • 2016 International Congress

    Sleep disorders in progressive supranuclear palsy

    B. Muinjonov, E. Giyaziddinova (Tashkent, Uzbekistan)

    Objective: Assessment of incidence of insomnia in PSP, its connection with motor, neuropsychological and behavior disorders, evaluation of impact on the quality of life. Background:…
  • 2016 International Congress

    Creative thinking and parkinsonism: Preliminary clinical data on the role of frontal area

    M. Canesi, M. Rusconi, E. Cereda, F. Moroni, A. Ranghetti, V. Cereda, G. Pezzoli (Milano, Italy)

    Objective: To evaluate divergent thinking (DT) by means of Abbreviated Torrance Test for Adults (ATTA) in Parkinsonism (PKS) with different deficit in cognitive functions. Background:…
  • 2016 International Congress

    THK-5351 tau-tracer uptake in patients with clinically diagnosed progressive supranuclear palsy

    S. Schönecker, M. Brendel, J. Havla, G. Höglinger, K. Bötzel, A. Danek, A. Rominger, J. Levin (Munich, Germany)

    Objective: The objective of our study is to investigate characteristics of THK-5351 binding in patients with clinically diagnosed progressive supranuclear palsy (PSP) and correlate tau-tracer…
  • 2016 International Congress

    Incidence of dystonia in patients with progressive supranuclear palsy

    E.I. Giyazitdinova, B.T. Muinjonov, G.S. Rakhimbaeva, Y.A. Musaeva (Taskent, Uzbekistan)

    Objective: To study the frequency of dystonic symptoms in progressive supranuclear palsy (PSP). Background: Progressive supranuclear palsy (PSP) is an uncommon brain disorder that affects…
  • 2016 International Congress

    Cognitive functioning in Parkinson’s disease and Parkinson plus syndrome

    S. Mina, V.K. Verma, K.S. Anand (New Delhi, India)

    Objective: Our study aimed to investigate and compare the cognitive functioning in PD and PPS. Background: Parkinson[s] disease (PD) is now known to be associated…
  • 2016 International Congress

    Assessment of subclinical cerebellar involvement in progressive supranuclear palsy using SUIT based volumetric analysis

    A. Lenka, L. George, K.R. Jhunjhunwala, S.A. Pasha, S. Mangalore, J. Saini, R. Yadav, P.K. Pal (Bangalore, India)

    Objective: To explore the pattern of cerebellar atrophy if any, in patients with Progressive Supranuclear Palsy (PSP) using the SUIT (Spatially Unbiased atlas template for…
  • 2016 International Congress

    Midbrain atrophy differentially progresses between Richardson’s Syndrome, progressive supranuclear palsy-parkinsonism and Parkinson’s disease: Longitudinal MRI study

    Y.E. Huh, M. Hwang, J.K. Park, J.W. Cho (Seoul, Korea)

    Objective: To elucidate different patterns of progression in midbrain atrophy between patients with Richardson's syndrome (PSP-RS), progressive supranuclear palsy-parkinsonism (PSP-P), and Parkinson's disease (PD) using…
  • 2016 International Congress

    Defining the pathology underlying cortico-basal syndrome: A European study

    R.C. Lamb, M.C. Darvell, J.D.S. Woodside, J.D. Rohrer, A.J. Lees, H.R. Morris (London, United Kingdom)

    Objective: To understand how clinical and biological features can help us define and explain the varying pathology that underlies corticobasal syndrome (CBS). Background: Corticobasal degeneration…
  • 2016 International Congress

    Tau PET in Parkinson syndromes. A new diagnostic tool?

    J. Hammes, G.N. Bischof, K. Giehl, Ö. Onur, A. Drzezga, T. Klockgether, T. van Eimeren (Cologne, Germany)

    Objective: To explore the potential of [F-18]-AV-1451 PET as a diagnostic tool in Parkinson plus syndromes. Background: Clinically, atypical Parkinson syndromes are often difficult to…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley